Registry for managing Helicobacter Pylori infection in Europe
European Registry on the Management of Helicobacter Pylori Infection
This study is trying to gather information on how adults in Europe are treated for Helicobacter pylori infections to see what works best and improve healthcare practices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Academic / other |
| Locations | 30 sites (Vienna and 29 other locations) |
| Trial ID | NCT02328131 on ClinicalTrials.gov |
What this trial studies
This observational study aims to systematically register and analyze the treatment, diagnosis, and management strategies for adult patients infected with Helicobacter pylori across various outpatient clinics in Europe. By evaluating the efficacy and safety of different treatment regimens and their cost-effectiveness, the study seeks to improve clinical practices and reduce the incidence of related complications such as peptic ulcers and gastric cancer. The data collected will help inform European Consensus guidelines for better healthcare efficiency in managing this prevalent infection.
Who should consider this trial
Good fit: Ideal candidates for this study are adult patients diagnosed with Helicobacter pylori infection.
Not a fit: Patients who are not infected with Helicobacter pylori or those who do not require treatment for the infection may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to optimized treatment strategies that improve patient outcomes and reduce healthcare costs associated with H. pylori infections.
How similar studies have performed: Other studies have shown success in managing H. pylori infections through systematic approaches, making this registry a valuable addition to existing knowledge.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infected adult patients by Helicobacter pylori Exclusion Criteria:
Where this trial is running
Vienna and 29 other locations
- Medical University Wien — Vienna, Austria (Recruiting)
- CHU de Charleroi, Charleroi — Charleroi, Belgium (Recruiting)
- Medical University of Sofia — Sofia, Bulgaria (Recruiting)
- University Hospital Merkur — Zagreb, Croatia (Recruiting)
- Charles University Faculty of Medicine — Prague, Czechia (Recruiting)
- Køge University Hospital — Køge, Denmark (Recruiting)
- University of Tartu — Tartu, Estonia (Recruiting)
- Herttoniemi Hospital, Helsinki — Helsinki, Finland (Recruiting)
- Hôpital Pellegrin — Bordeaux, France (Recruiting)
- Medizin Uni Magdeburg — Magdeburg, Germany (Recruiting)
- Gastroenterology Clinic, Henry Dunant Hospital — Athens, Greece (Recruiting)
- Ferencváros Health Centre, Gaastroenterology — Budapest, Hungary (Recruiting)
- Adelaide Meath Hospital, Dublin — Dublin, Ireland (Recruiting)
- Studio Gasbarrini — Roma, Italy (Recruiting)
- Digestive Diseases Centre GASTRO — Riga, Latvia (Recruiting)
- Lithuanian university of Health Sciences Hospital — Kaunas, Lithuania (Recruiting)
- Ikazia Ziekenhuis/ Erasmus Medisch Centrum — Rotterdam, Netherlands (Recruiting)
- Central Hospital of Ostfold — Fredrikstad, Norway (Recruiting)
- Departament of Gastroenterology, Medical Centre for Postgraduate Education — Warsaw, Poland (Recruiting)
- Porto — Porto, Portugal (Recruiting)
- Timisoara — Timișoara, Romania (Recruiting)
- Central Scientific Research Institute of Gastroenterology — Moscow, Russia (Recruiting)
- Clinical Center of Serbia — Belgrade, Serbia (Recruiting)
- DC Rogaska — Rogaška Slatina, Slovenia (Recruiting)
- Hospital de La Princesa, Madrid — Madrid, Spain (Recruiting)
- Uppsala University Hospital. — Uppsala, Sweden (Recruiting)
- University Hospital Basel — Basel, Switzerland (Recruiting)
- Dokuz Eylul University School of Medicine — Izmir, Turkey (Türkiye) (Recruiting)
- National Medical University — Kiev, Ukraine (Recruiting)
- Leeds General Infirmiry Hospital — Leeds, United Kingdom (Recruiting)
Study contacts
- Principal investigator: Javier Pérez Gisbert, MD — Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- Study coordinator: Javier Pérez Gisbert, MD
- Email: javier.p.gisbert@gmail.com
- Phone: +34 913093911
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.